FOXP3 and neoplasm: FACS and IHC analyses showed that recruitment of CD3 + /CD8 + cytotoxic T cells, which suppress cancer cells, increased and that tumor-friendly CD3 + /CD4 + /FoxP3 + T cells decreased upon co-treatment with PLAG + aPD-L1.